266 related articles for article (PubMed ID: 4796512)
1. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells.
Dano K
Biochim Biophys Acta; 1973 Oct; 323(3):466-83. PubMed ID: 4796512
[No Abstract] [Full Text] [Related]
2. Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells.
Skovsgaard T
Cancer Res; 1978 Jun; 38(6):1785-91. PubMed ID: 647687
[No Abstract] [Full Text] [Related]
3. Calcium modifies the accumulation and retention of daunorubicin by Ehrlich ascites carcinoma.
Murray SL; Du Vall EM; Slater LM
Cancer Chemother Pharmacol; 1984; 13(1):69-70. PubMed ID: 6733845
[TBL] [Abstract][Full Text] [Related]
4. Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells.
Skovsgaard T
Biochem Pharmacol; 1978; 27(8):1221-7. PubMed ID: 567991
[No Abstract] [Full Text] [Related]
5. Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells.
Friche E; Skovsgaard T; Nissen NI
Cancer Chemother Pharmacol; 1987; 19(1):35-9. PubMed ID: 3815723
[TBL] [Abstract][Full Text] [Related]
6. Transport and binding of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells.
Skovsgaard T
Biochem Pharmacol; 1977 Feb; 26(3):215-22. PubMed ID: 14644
[No Abstract] [Full Text] [Related]
7. Subcellular localization of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells.
Londos-Gagliardi D; Aubel-Sadron G; Maral R; Trouet A
Eur J Cancer (1965); 1980 Jun; 16(6):849-54. PubMed ID: 7408932
[No Abstract] [Full Text] [Related]
8. Comparative nuclear and cellular incorporation of daunorubicin, doxorubicin, carminomycin, marcellomycin, aclacinomycin A and AD 32 in daunorubicin-sensitive and -resistant Ehrlich ascites in vitro.
Seeber S; Loth H; Crooke ST
J Cancer Res Clin Oncol; 1980; 98(2):109-18. PubMed ID: 6938517
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells.
Skovsgaard T
Cancer Res; 1978 Dec; 38(12):4722-7. PubMed ID: 719649
[No Abstract] [Full Text] [Related]
10. Mechanism of resistance to anthracyclines and vinca alkaloids.
Danø K; Skovsgaard T; Nissen NI; Friche E; Di Marco A
Prog Clin Biol Res; 1983; 132C():231-46. PubMed ID: 6579564
[TBL] [Abstract][Full Text] [Related]
11. Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell lines.
Sehested M; Skovsgaard T; van Deurs B; Winther-Nielsen H
J Natl Cancer Inst; 1987 Jan; 78(1):171-9. PubMed ID: 3467125
[TBL] [Abstract][Full Text] [Related]
12. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
Friche E; Demant EJ; Sehested M; Nissen NI
Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
[TBL] [Abstract][Full Text] [Related]
13. Circumvention of resistance to daunorubicin by N-acetyldaunorubicin in Ehrlich ascites tumor.
Skovsgaard T
Cancer Res; 1980 Apr; 40(4):1077-83. PubMed ID: 7357538
[TBL] [Abstract][Full Text] [Related]
14. Interaction between daunorubicin and chromatin from Ehrlich ascites tumor cells.
Sabeur G; Genest D; Aubel-Sadron G
Biochem Biophys Res Commun; 1979 May; 88(2):722-9. PubMed ID: 465065
[No Abstract] [Full Text] [Related]
15. Ion transport of ouabain resistant and sensitive Ehrlich ascites carcinoma cells.
Mayhew E
J Cell Physiol; 1972 Jun; 79(3):441-52. PubMed ID: 5064753
[No Abstract] [Full Text] [Related]
16. Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: evidence for nuclear drug accumulation and redistribution in resistant cells.
Marquardt D; Center MS
Cancer Res; 1992 Jun; 52(11):3157-63. PubMed ID: 1591727
[TBL] [Abstract][Full Text] [Related]
17. Characterization of tumor cell resistance to 4'-deoxy-4'-iododoxorubicin developed in Ehrlich ascites cells in vivo.
Friche E; Danks MK; Beck WT
Cancer Res; 1992 Oct; 52(20):5701-6. PubMed ID: 1356619
[TBL] [Abstract][Full Text] [Related]
18. A model for computer simulation of P-glycoprotein and transmembrane delta pH-mediated anthracycline transport in multidrug-resistant tumor cells.
Demant EJ; Sehested M; Jensen PB
Biochim Biophys Acta; 1990 Nov; 1055(2):117-25. PubMed ID: 2242381
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic investigations on a Ehrlich ascites tumor, and four sublines resistant to daunomycin, adriamycin, vincristine and vinblastine.
Hasholt L; Dan0 K
Hereditas; 1974; 77(2):303-10. PubMed ID: 4141349
[No Abstract] [Full Text] [Related]
20. Ca2+-transport inhibition by the antitumor agents adriamycin and daunomycin.
Anghileri LJ
Arzneimittelforschung; 1977; 27(6):1177-80. PubMed ID: 578437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
